Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Hepatology. 2016 Mar 22;63(6):1796–1808. doi: 10.1002/hep.28497

Figure 2. Changes in mean ICER with increased PWID treatment rates in prison (2.5%-25% after referral).

Figure 2

Base-case analysis assumes a mean of 2.5% PWID treated after referral in prison. (a) Doubled testing with status quo treatments compared to status quo testing/treatment. (b) Double testing with 8–12 week IFN-free DAAs compared to doubled testing with status quo treatments.